Yishenyangsui granule for degenerative cervical myelopathy: a randomized, double-blind, placebo-controlled trial with long-term follow-up
ObjectiveThis randomized controlled trial aims to evaluate the efficacy and safety of Yishenyangsui granule for treating Degenerative Cervical Myelopathy.Materials and methodsA randomized, double-blind, placebo-controlled clinical trial was conducted with 152 participants recruited from three center...
Saved in:
Main Authors: | He Yin, Xin Chen, Zhiwei Liu, Bo Xu, Zhefeng Jin, Yan Liu, Baoyu Qi, Bin Tang, Ping Wang, Fanping Xu, Xu Wei, Jie Yu, Liguo Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1542231/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intramedullary Stress and Strain Correlate with Neurological Dysfunction in Degenerative Cervical Myelopathy
by: Mahmudur Rahman, et al.
Published: (2025-01-01) -
Diagnostic Dilemmas in Carpal Tunnel Syndrome and Cervical Spine Disorders: A Comprehensive Review
by: Yuki Hara, et al.
Published: (2025-01-01) -
Differences in Transdiaphragmatic Pressure of Dogs Suffering from Cervical or Thoracolumbar Myelopathy Anaesthetised with Isoflurane
by: Eirini Sarpekidou, et al.
Published: (2025-01-01) -
Prospective Study of Posterior Cervical Foraminotomy for Cervical Radiculopathy in Absenceof Myelopathy
by: Umesh D. Jain, et al.
Published: (2023-01-01) -
White cord syndrome: A rare complication of adequate spinal cord decompression. A case report and review of current literature
by: Daan N. de Groot, et al.
Published: (2025-01-01)